{"disease":{"id":"irritation","name":"irritation","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"polysorbate-80","indication_name":"Burning and irritation relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Polyethoxylated Sorbitan Monooleate","generic_name":"POLYSORBATE 80","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"polysorbate-80","indication_name":"Protection against further irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Polyethoxylated Sorbitan Monooleate","generic_name":"POLYSORBATE 80","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"olive-oil","indication_name":"Minor skin irritation and itching relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"OLIVE OIL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid Emulsion [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"propylene-glycol-0-3","indication_name":"Eye Irritation Relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Propylene Glycol 0.3%","company_name":"Innovative Medical","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"levomenthol","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Salonpas","generic_name":"LEVOMENTHOL","company_name":"","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily M member 8","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"levomenthol","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Salonpas","generic_name":"LEVOMENTHOL","company_name":"","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily M member 8","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"hyoscyamine","indication_name":"Urinary Tract Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"(-)-Atropine","generic_name":"Hyoscyamine","company_name":"University of Kansas Medical Center","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"hyoscyamine","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"allantoin","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Allantol","generic_name":"ALLANTOIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"allantoin","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"aspartame","indication_name":"skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Addiclenz","generic_name":"ASPARTAME","company_name":"Deseret Biologicals, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"syrup","indication_name":"minor throat irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Formula 3 Cough Syrup","generic_name":"SYRUP","company_name":"Vitality Works, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"syrup","indication_name":"bronchial irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Formula 3 Cough Syrup","generic_name":"SYRUP","company_name":"Vitality Works, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"myrrh","indication_name":"minor skin irritations","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"First Aid 4pc MIni Stick Kit","generic_name":"MYRRH","company_name":"Spry Life LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"aluminum-acetate","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Domeboro","generic_name":"ALUMINUM ACETATE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"starch","indication_name":"minor skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotrimin Daily Sweat and Odor Control","generic_name":"STARCH","company_name":"Bayer HealthCare LLC.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"dextran","indication_name":"redness of the eye due to minor eye irritations","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GoodSense Eye Drops Advanced Relief Moisturizer","generic_name":"DEXTRAN","company_name":"Allergan","drug_phase":"marketed","molecular_target":"","drug_class":"Plasma Volume Expander [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"dextran","indication_name":"further irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GoodSense Eye Drops Advanced Relief Moisturizer","generic_name":"DEXTRAN","company_name":"Allergan","drug_phase":"marketed","molecular_target":"","drug_class":"Plasma Volume Expander [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"borneol","indication_name":"irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hemorrhoid, Fissure, ProctalgiaSuppositories","generic_name":"BORNEOL","company_name":"WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"Non-Standardized Chemical Allergen [EPC]","quality_score":28,"revenue":null,"mechanism":"Proctalgia Suppositories works by interacting with the anal tissue to reduce symptoms of irritation, pain, and discomfort."},{"drug_id":"borneol","indication_name":"anorectal irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hemorrhoid, Fissure, ProctalgiaSuppositories","generic_name":"BORNEOL","company_name":"WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"Non-Standardized Chemical Allergen [EPC]","quality_score":28,"revenue":null,"mechanism":"Proctalgia Suppositories works by interacting with the anal tissue to reduce symptoms of irritation, pain, and discomfort."},{"drug_id":"butamben","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Butesin","generic_name":"BUTAMBEN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":10,"revenue":null,"mechanism":"Butesin works by interacting with the nervous system to reduce pain and itching sensations."},{"drug_id":"bupivacaine","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"cetylpyridinium","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ceepryn","generic_name":"CETYLPYRIDINIUM","company_name":"","drug_phase":"marketed","molecular_target":"Caspase-2","drug_class":"cetylpyridinium","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"bupivacain","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"laurocapram","indication_name":"minor skin irritations","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"The Melanin Skin Protectant Cream","generic_name":"LAUROCAPRAM","company_name":"Reedfresh Co., LTD","drug_phase":"marketed","molecular_target":"","drug_class":"Amide Local Anesthetic [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"benzyl-alcohol","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ulesfia","generic_name":"BENZYL ALCOHOL","company_name":"Shionogi","drug_phase":"marketed","molecular_target":"","drug_class":"Pediculicide [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"secbutabarbital","indication_name":"Urinary Tract Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"secbutabarbital","company_name":"","drug_phase":"unknown","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocaine-hydrochloride","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"benzethonium","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzetonium Chloride","generic_name":"BENZETHONIUM","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"benzethonium","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"cinchocaine","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dibucaine","generic_name":"cinchocaine","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"dyclonine","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dyclone","generic_name":"DYCLONINE","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"dyclonine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dyclonine","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dyclone","generic_name":"DYCLONINE","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"dyclonine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"flavoxate","indication_name":"Urinary Tract Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Urispas","generic_name":"FLAVOXATE","company_name":"","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Cholinergic Muscarinic Antagonist","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"benzalkonium","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzododecinium","generic_name":"BENZALKONIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"benzalkonium","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"benzalkonium","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzododecinium","generic_name":"BENZALKONIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"benzalkonium","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"benzocaine","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norcaine","generic_name":"BENZOCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"benzocaine","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norcaine","generic_name":"BENZOCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"terbutaline","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"zinc-acetate","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Galzin","generic_name":"ZINC ACETATE","company_name":"Eton","drug_phase":"marketed","molecular_target":"","drug_class":"zinc acetate","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"dextromethorphan","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Delsym","generic_name":"dextromethorphan","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 46, Solute carrier family 22 member 1, Cytochrome P450 2D6","drug_class":"Antitussive (non-opioid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"tetracaine","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tetracaine Hydrochloride","generic_name":"TETRACAINE","company_name":"Alcon Labs","drug_phase":"marketed","molecular_target":"Sodium channel protein type 7 subunit alpha","drug_class":"Ester Local Anesthetic","quality_score":10,"revenue":null,"mechanism":"Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted."},{"drug_id":"pramocaine","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pramocaine","company_name":"","drug_phase":"unknown","molecular_target":"Sigma non-opioid intracellular receptor 1, Sodium channel alpha subunits; brain (Types I, II, III), Membrane-associated progesterone receptor component 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"resorcinol","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"resorcinol","company_name":"","drug_phase":"unknown","molecular_target":"Carbonic anhydrase 12, Carbonic anhydrase 14, Carbonic anhydrase 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Mouth Irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Skin irritation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":10,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."}],"pipeline":[],"offLabel":[],"totalMarketed":49,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06538662","title":"An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":283,"lead_sponsor_name":"Alcon Research","has_results":false},{"nct_id":"NCT03397862","title":"A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Corium, Inc.","has_results":false},{"nct_id":"NCT04624867","title":"Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Noven Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT07390162","title":"The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of Oral Mucosal Pressure Injuries","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":230,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT04094025","title":"Irritation and Sensitization Study of d-Amphetamine Transdermal System","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"Noven Therapeutics","has_results":false},{"nct_id":"NCT06810856","title":"HRIPT Study to Evaluate the Irritation and Allergenic Potential of Medical-grade Norway Spruce (Picea Abies) Resin Salve (Abilar)","phase":"NA","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Repolar Pharmaceuticals Oy","has_results":false},{"nct_id":"NCT03180944","title":"Lower Lugol's Solution Concentration on Reducing the Adverse Symptoms of Chromoendoscopy With Iodine Staining","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT04436666","title":"Virtual Reality, Ice Application and Self-injection and Self-test Fair, Pain and State Anxiety","phase":"NA","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Inonu University","has_results":false},{"nct_id":"NCT03052452","title":"My Nutritional Health App Testing","phase":"","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT05225610","title":"Valsalva Manoeuvre and Intravenous Dexmedetomidine on Attenuating Pain During Propofol Injection in Upper GIT Endoscopy","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT03420560","title":"A Warmer Temperature Decrease Propofol Injection Pain","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Xingui Dai","has_results":false},{"nct_id":"NCT04555980","title":"Warm Patch Decrease Propofol Injection Pain","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"First People's Hospital of Chenzhou","has_results":false},{"nct_id":"NCT07100912","title":"Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":113,"lead_sponsor_name":"Amazentis SA","has_results":false},{"nct_id":"NCT06884215","title":"Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Amazentis SA","has_results":false},{"nct_id":"NCT05079607","title":"Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Amazentis SA","has_results":false},{"nct_id":"NCT07517874","title":"Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Amazentis SA","has_results":false},{"nct_id":"NCT06805903","title":"Validation of TRansanal Irrigation Adherence scaLe (TRIAL)","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03681678","title":"Laser Therapy for Treatment of Urogenital Symptoms in Women","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Corewell Health East","has_results":true},{"nct_id":"NCT05864352","title":"The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"University of Massachusetts, Lowell","has_results":false},{"nct_id":"NCT06596733","title":"Vit-A-Vision® Clinical Investigation","phase":"NA","overall_status":"RECRUITING","enrollment_count":77,"lead_sponsor_name":"OmniVision GmbH","has_results":false},{"nct_id":"NCT05615961","title":"Effect of Probiotics on Endurance Athletes' Microbiome at Rest and Post-race","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Liverpool John Moores University","has_results":false},{"nct_id":"NCT04582032","title":"Effects of Cyclooxygenase (COX) 1-2 Inhibitors on Prevention of Rocuronium Injection Pain","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT06020638","title":"Determining The Effects Of Nasopharyngeal Suction","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Fenerbahce University","has_results":false},{"nct_id":"NCT05269823","title":"Topical Ice-therapy for Intravitreal Injections","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT07208708","title":"Patient Satisfaction With At-home Dental Bleaching Using Orthodontic Retainers With Different Margin Designs","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Universidad Rey Juan Carlos","has_results":false},{"nct_id":"NCT03690908","title":"Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic Disease","phase":"","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT03301870","title":"A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"UNION therapeutics","has_results":false},{"nct_id":"NCT02968446","title":"Effect of Vitamin D After Application With Valchlor","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"University Hospitals Cleveland Medical Center","has_results":false},{"nct_id":"NCT06119750","title":"4-Day Primary Irritation Patch Test of MIS Solution","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Next Science TM","has_results":false},{"nct_id":"NCT04356352","title":"Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":33,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT07355673","title":"The Influence of Isolation Techniques in Gingival Irritation During an In-office Bleaching","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of Santiago de Compostela","has_results":false},{"nct_id":"NCT05817565","title":"Physical Therapy on Phrenic Nerve Function","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT05276102","title":"The Effects of Repeated Exposure to Antiseptics During COVID-19 Pandemic on Skin Parameters","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"University of Split, School of Medicine","has_results":false},{"nct_id":"NCT05221333","title":"Sorrel 25R Injector - Sorrel Clinical Study Protocol","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Eitan Medical","has_results":false},{"nct_id":"NCT03704727","title":"The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University of Copenhagen","has_results":false},{"nct_id":"NCT02400320","title":"Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}